<h4>Background</h4>The E4 variant of Apolipoprotein E (APOE) is a primary genetic susceptibility risk factor for late-onset Alzheimer's disease and has been implicated in cerebrovascular dysfunction. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.